Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial

BACKGROUND: Placebo medications, by definition, are composed of inactive ingredients that have no physiological effect on symptoms. Nonetheless, administration of placebo in randomized controlled trials (RCTs) and in clinical settings has been demonstrated to have significant impact on many physical...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballou, Sarah, Kaptchuk, Ted J., Hirsch, William, Nee, Judy, Iturrino, Johanna, Hall, Kathryn T., Kelley, John M., Cheng, Vivian, Kirsch, Irving, Jacobson, Eric, Conboy, Lisa, Lembo, Anthony, Davis, Roger B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445390/
https://www.ncbi.nlm.nih.gov/pubmed/28545508
http://dx.doi.org/10.1186/s13063-017-1964-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445390/
https://www.ncbi.nlm.nih.gov/pubmed/28545508
http://dx.doi.org/10.1186/s13063-017-1964-x

Ejemplares similares